PharmaLectures.com

Courses › GMP, GDP, quality and compliance › GMP for biologics: Part II, Annex 2 and where small-molecule habits go wrong

GMP for biologics: Part II, Annex 2 and where small-molecule habits go wrong

Your biologics team answers the inspector from Annex 2, not from small-molecule habits.

Biologics GMP is the set of good manufacturing practice rules for medicines made from living cells or organisms, such as vaccines, monoclonal antibodies and blood products. In the European Union, Annex 2 of the EU GMP guide, revised in 2018, adds to Part I and Part II with rules on cell banks and seed lots, containment, viral safety, personnel hygiene and in-process control, because biological processes vary more than chemical synthesis. Advanced therapy medicinal products follow a separate Part IV. This course shows where small-molecule habits go wrong in biologics.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Biologics staffwho it is written for

Why biologics GMP training matters

An inspector walks into your bioreactor suite and asks why the cleaning rationale reads like a tablet line. Nobody on shift can cite Annex 2. The finding lands, the batch waits on release, and your team rewrites procedures while the schedule slips.

What changes after this course

Your operators and supervisors justify each biological process control from Annex 2 and stop carrying chemical assumptions into aseptic work. You hold a certificate for every learner and a training record per person, ready when the inspector asks.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

Biologics GMP training: what this course gives your people

Your quality team stops answering inspector questions with rules written for tablets. They open Annex 2 of the European Union Good Manufacturing Practice guide, find the paragraph that applies to your cell line, and adjust the facility and equipment plan to match. The deviation you used to meet at inspection gets found at the design table.

The Qualified Person signs off biological batches sooner, because the in-process controls and the pooled harvest batch definition already answer what Annex 16 makes them ask before certification. Your production staff write master batch records under Chapter 4 with the trace from cell bank to finished vial built in, right the first time.

At the next inspection, operators explain why a cleaning routine for chemical residues does not remove protein, and why sanitization is validated differently for live organisms. Questions on adventitious agents get an answer from a risk assessment you already hold. Nobody leaves the room to find a document.

On the floor, staff stop treating a fermenter like a mixing tank. They know why access to the critical area is limited, why starting materials and master cell banks follow their own protocols, and what to record at each step. Your Site Master File then describes what your site really does.

Who needs biologics GMP training

  • Biologics Production Supervisor

    Your operators treat a bioreactor like a chemical mixing tank, and you need them to follow the hygiene and access rules of Annex 2 without a reminder at every shift handover.

  • Quality Assurance Specialist

    A pooled harvest batch record lands on your desk and you cannot tell if the in-process controls show homogeneity. You leave with the Annex 2 questions to ask before you sign.

  • Regulatory Affairs Associate

    The inspector asks how your multi-product site keeps cell lines apart. You have a documented risk assessment ready, and the words to walk the inspector through it.

  • Qualified Person

    You hesitate to certify a biological batch because the record lacks the cell bank traceability Annex 2 expects. You know what to ask for early, so the batch is not waiting on a Friday call.

Roles: Quality assurance and Qualified Person, Production and engineering

Businesses: Biologics and biosimilars

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: any jurisdiction

Courses are in English. Other languages on request.

After this course your people can

  1. Map each requirement of European Union Good Manufacturing Practice Annex 2 to a named step in your own biological process.
  2. Write a quality risk assessment that addresses adventitious agents in biological starting materials and master cell banks.
  3. Set personnel access and hygiene rules for critical areas that match Annex 2 and can be shown to an inspector.
  4. Explain why protein residues need their own cleaning validation and why sanitization for live organisms is validated differently.
  5. Draft a master batch record under Chapter 4 that traces a finished vial back to its working cell bank.
  6. Answer an inspector's question on in-process controls, pooling and batch release for biologicals, with the document to back it up.

What the company gets

  • A cleaning rationale, a risk assessment and a batch record that name Annex 2 sit ready before the inspector arrives.
  • Fewer production holds, because operators stop carrying chemical assumptions into aseptic processing and open fermentation.
  • Your Qualified Person gets batch files that already answer the Annex 16 questions, so release does not wait on follow-up calls.
  • You hold a certificate for each learner and a training record per person, ready for any inspector or customer audit.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Quality assurance and Qualified PersonExpanded10 h
Production and engineeringExpanded10 h

Biologics GMP course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map your biologics to European Union Good Manufacturing Practice Annex 2

    • Why a control that suits a tablet line fails on a biological product, in Annex 2 terms.
    • How to place your substance in the right Annex 2 category before the inspector asks.
    • The Annex 2 definitions your operators use on the shop floor without a trip to the quality office.
  2. 2Spot the quality risks hidden in biological starting materials

    • What to do when a supplier cannot show where a biological starting material came from.
    • How to write the risk assessment that shows your multi-product site keeps cell lines apart.
    • The starting material risks a small-molecule model never asks about, and the questions that expose them.
  3. 3Set Annex 2 hygiene and access rules your personnel actually follow

    • Why a general health check is not enough for staff who handle cell cultures.
    • How to limit critical area access so only qualified operators touch the process, and prove it.
    • The hygiene habits that keep human-borne contamination out of your cell cultures.
  4. 4Qualify biologics facilities and equipment to pass Annex 2 inspection

    • How to brief engineers so the air handling design meets Annex 2 containment needs the first time.
    • The difference between cleaning and sanitization validation when the contaminant is alive.
    • When dedicated equipment is required and when a multi-use suite stays compliant.
  5. 5Control biological starting materials and master cell banks

    • How to keep cell lines apart so a mix-up never reaches the production suite.
    • The records that show your master and working cell banks stayed stable.
    • What an inspector checks when tracing a raw material back to its biological source.
  6. 6Run biological production and aseptic processing without deviations

    • How to protect inoculum preparation from the room around it.
    • Where in aseptic processing operators let adventitious agents in, and the habit that stops it.
    • What to monitor in the environment during open fermentation steps, and why.
  7. 7Set in-process controls and support batch release for biologicals

    • Why pooled biological harvests need a batch definition your Qualified Person can defend.
    • How in-process control results give your Qualified Person a reason to certify, not a reason to wait.
    • The attributes to measure before the product moves to the next stage, and where to record them.
  8. 8Run quality control tests that fit biological medicinal products

    • How to validate an analytical method for a product with no simple chemical structure.
    • The way to manage reference standards when you test biological potency.
    • What to do when identity and purity tests return variable biological results.
  9. 9Write master batch records that meet Chapter 4 and Annex 2

    • How to build a master batch record that allows for the natural variability of living cells.
    • How Chapter 4 batch records and Annex 2 together support traceability from cell bank to finished vial.
    • How to store retained biological samples under their labelled conditions, and document it.
  10. 10Separate biologics facility requirements from small-molecule ones

    • How environmental monitoring for sterile biologics differs from monitoring for non-sterile chemicals.
    • Why protein residues survive a cleaning routine built for chemical residues.
    • When facility design must put biological containment ahead of simple dust extraction.
  11. 11Adapt process controls when your site moves from chemicals to biologics

    • Why starting material variability is harder to manage for cell lines than for chemical powders.
    • How adventitious agent control shapes the process strategy you write for a biologic.
    • When pooling and batch homogeneity need a written rationale, and what it should say.
  12. 12Answer inspector questions on Annex 2 biological compliance

    • How to lay out master batch records so the inspector sees compliance in the first pages.
    • The biological manufacturing deviations that can draw a major deficiency, and how to prevent them.
    • What to say when an inspector questions your continuous monitoring strategy.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about biologics GMP training

Why do biologics need extra GMP rules?

Biological processes depend on living cells or organisms, so the product can vary with small changes in starting materials, culture conditions or handling, and it can be contaminated by viruses or other agents that chemical processes do not face. Many quality attributes also cannot be fully confirmed by testing the final product. Annex 2 therefore puts more weight on controlling starting materials and the process itself.

What is a cell bank system?

A cell bank system keeps a characterised master cell bank, from which working cell banks are prepared, so every production run starts from the same well-tested cells. EU GMP Annex 2 requires cell banks to be established under suitable conditions, tested, stored securely, often split across locations, and documented, with limits on the number of generations or passages between the bank and the final product.

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Biologics staff. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team